Correction to: Management of immune thrombocytopenia in multiple sclerosis patients treated with alemtuzumab: a Belgian consensus (Acta Neurologica Belgica, (2018), 118, 1, (7-11), 10.1007/s13760-018-0882-3)

The article Management of immune thrombocytopenia in multiple sclerosis patients treated with alemtuzumab: a Belgian consensus, written by Lambert et al. was originally published electronically on the publisher’s internet portal on 27 January 2018 without open access. With the author(s)' decision to opt for Open Choice the copyright of the article changed on March 3, 2018 to © The Author(s) 2018 and the article is forthwith distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creat iveco mmons .org/licen ses/by/4.0/), which permits use, duplication,... Mehr ...

Verfasser: Lambert, Catherine
Dubois, Bénédicte
Dive, Dominique
Lysandropoulos, Andreas
Selleslag, Dominik
Vanopdenbosch, Ludo
Van Pesch, Vincent
Vanwijmeersch, Bart
Janssens, Ann
Dokumenttyp: Artikel
Erscheinungsdatum: 2018
Schlagwörter: Généralités / Alemtuzumab / Multiple sclerosis / Immune thrombocytopenia / Platelet count / Practical recommendations
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-27303349
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/270477